To register for this live symposium:
Not able to attend in person?
Register for the live video stream:
*This video stream is a live broadcast of the symposium and can be viewed on a laptop or tablet.
Date and Location
This activity is supported by an educational grant from Lilly and Amgen.
Only one-third of individuals who are eligible for migraine preventive regimens actually receive them, and over 75% of these individuals become noncompliant due to adverse effects and lack of efficacy. Recently, calcitonin gene-related peptide (CGRP) antagonists were approved for preventive treatment against migraines, and they have been proven to be more effective and safer than previous therapies. Pharmacists have an important role in educating patients on medication and proper administration along with encouraging patient compliance in order for the patient to receive optimal therapeutic effects.
Type of Activity:
At the completion of this activity, the participant will be able to:
- Examine the clinical features associated with migraines
- Explain safety and efficacy of newly approved agents for migraines
- Identity opportunities for pharmacists to intervene to optimize migraine treatment and prevent adverse drug effects
No additional fee is required to attend this CPE-accredited symposium activity; however, registration to APhA2019 is required.
Pharmacy Times Continuing Education™ (PTCE) strives to provide the highest level of service. However, unforeseen circumstances may necessitate the rescheduling or cancellation of live events, including, but not limited to, webinars hosted by PTCE. PTCE reserves the right to cancel an event without notice. PTCE will not be responsible for any expenditure incurred due to the cancellation.
Continuing professional education (CPE) activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
Americans with Disabilities Act
Pharmacy Times Continuing Education™ (PTCE) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call 609-378-3701.
For questions about this live CPE activity, please contact: firstname.lastname@example.org
2 Clarke Drive | Cranbury, NJ 08512
P: 800.597.6372 | F: 609.228.5894
Nikki Hahn, PharmD, BCACP
Clinical Pharmacy Specialist – Neurology
Kaiser Permanente of Colorado
Paul G. Mathew, MD, FAAN, FAHS
Assistant Professor of Neurology
Harvard Medical School
Director of Visiting Scholars Program
Brigham & Women’s Hospital
Department of Neurology, John R. Graham Headache Center
Co-Chief Medical Editor
Saturday, March 23, 2019
Time*: 6:00 AM – 6:30 AM (Registration & Breakfast) | 6:30 AM – 8:00 AM (Main Session)
Grand Hyatt Seattle
721 Pine Street
Seattle, WA 98101
Room: Princessa Ballroom
A Satellite Symposium to be conducted in conjunction with APhA2019.
||Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEUs) under the ACPE universal activity number 0290-0000-19-012-L01-P. The activity is available for CE credit for March 23, 2019.
All participants who attended the live symposium need to log on to their Pharmacy Times Continuing Education™ account on www.pharmacytimes.org to complete an online evaluation form and request their credit. Credit must be requested no later than May 23, 2019.
Faculty disclosures will be provided prior to the presentation.
The following contributors have no relevant financial relationships with commercial interests to disclose:
Pharmacy Times Continuing Education™
Planning Staff – Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Olivia Mastrodonato; Marisa Fennekohl; Susan Pordon; and Brianna Winters.
An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.